Coxsackievirus A6 2C protein antagonizes IFN-β production through MDA5 and RIG-I depletion

J Virol. 2023 Nov 30;97(11):e0107523. doi: 10.1128/jvi.01075-23. Epub 2023 Oct 17.

Abstract

Coxsackievirus A6 (CV-A6) is a major emerging pathogen associated with atypical hand, foot, and mouth disease and can cause serious complications such as encephalitis, acute flaccid paralysis, and neurorespiratory syndrome. Therefore, revealing the associated pathogenic mechanisms could benefit the control of CV-A6 infections. In this study, we demonstrate that the nonstructural 2CCV-A6 suppresses IFN-β production, which supports CV-A6 infection. This is achieved by depleting RNA sensors such as melanoma differentiation-associated gene 5 and retinoic acid-inducible gene I (RIG-I) through the lysosomal pathway. Such a function is shared by 2CEV-A71 and 2CCV-B3 but not 2CCV-A16, suggesting the latter might have an alternative way to promote viral replication. This study broadens our understanding of enterovirus 2C protein regulation of the RIG-I-like receptor signaling pathway and reveals a novel mechanism by which CV-A6 and other enteroviruses evade the host innate immune response. These findings on 2C may provide new therapeutic targets for the development of effective inhibitors against CV-A6 and other enterovirus infections.

Keywords: 2C protein; HFMD; IFN-β; MDA5; RIG-I; coxsackievirus A6; enterovirus.

MeSH terms

  • Coxsackievirus Infections* / metabolism
  • Coxsackievirus Infections* / virology
  • Enterovirus A, Human / genetics
  • Enterovirus Infections / metabolism
  • Enterovirus Infections / virology
  • Hand, Foot and Mouth Disease / virology
  • Humans
  • Immunity, Innate
  • Interferon-beta / metabolism

Substances

  • 2C protein, viral
  • Interferon-beta
  • IFIH1 protein, human
  • RIGI protein, human